Intralesional interferon alfa for treatment of recurrent lentigo maligna of the eyelid in a patient with primary acquired melanosis.
Carucci
J A
JA
Leffell
D J
DJ
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005142:Eyelid Neoplasms / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D018327:Hutchinson's Melanotic Freckle / Q000150:complications / Q000188:drug therapy*; D015552:Injections, Intralesional; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008548:Melanosis / Q000150:complications*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000150:complications / Q000188:drug therapy*
D000970:Antineoplastic Agents; D016898:Interferon-alpha